TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,762,666 | -30.9% | 1,167,783 | +105.3% | 0.01% | -27.8% |
| Q2 2023 | $14,128,719 | +161.5% | 568,789 | +58.3% | 0.02% | +125.0% |
| Q1 2023 | $5,403,150 | +138.6% | 359,252 | +87.7% | 0.01% | +166.7% |
| Q4 2022 | $2,264,392 | -99.9% | 191,411 | -41.5% | 0.00% | 0.0% |
| Q3 2022 | $1,935,384,000 | +188.4% | 326,923 | +107.0% | 0.00% | +200.0% |
| Q2 2022 | $671,130,000 | -35.2% | 157,913 | +45.1% | 0.00% | 0.0% |
| Q1 2022 | $1,035,278,000 | -50.3% | 108,862 | -0.6% | 0.00% | -66.7% |
| Q4 2021 | $2,081,127,000 | +174.1% | 109,533 | +380.1% | 0.00% | +200.0% |
| Q3 2021 | $759,283,000 | +324.1% | 22,815 | +394.3% | 0.00% | – |
| Q2 2021 | $179,055,000 | -80.6% | 4,616 | -75.8% | 0.00% | -100.0% |
| Q1 2021 | $921,102,000 | -82.4% | 19,110 | -81.0% | 0.00% | -90.0% |
| Q4 2020 | $5,233,628,000 | +649.2% | 100,608 | +285.4% | 0.01% | +900.0% |
| Q3 2020 | $698,543,000 | +198.2% | 26,104 | +117.0% | 0.00% | – |
| Q2 2020 | $234,286,000 | -44.5% | 12,027 | -71.9% | 0.00% | -100.0% |
| Q1 2020 | $421,910,000 | +276.5% | 42,877 | +324.7% | 0.00% | – |
| Q4 2019 | $112,054,000 | +65.3% | 10,095 | -16.4% | 0.00% | – |
| Q3 2019 | $67,779,000 | +12.4% | 12,071 | +73.1% | 0.00% | – |
| Q2 2019 | $60,308,000 | -42.8% | 6,972 | -46.8% | 0.00% | – |
| Q1 2019 | $105,461,000 | +566.0% | 13,117 | +239.6% | 0.00% | – |
| Q4 2018 | $15,834,000 | -73.8% | 3,862 | -64.2% | 0.00% | – |
| Q3 2018 | $60,379,000 | -59.0% | 10,782 | -3.6% | 0.00% | – |
| Q2 2018 | $147,096,000 | -3.8% | 11,186 | +3.9% | 0.00% | – |
| Q1 2018 | $152,849,000 | +62.0% | 10,764 | -6.5% | 0.00% | – |
| Q4 2017 | $94,374,000 | +57.4% | 11,509 | +127.5% | 0.00% | – |
| Q3 2017 | $59,961,000 | +10.9% | 5,060 | -6.0% | 0.00% | – |
| Q2 2017 | $54,079,000 | +1373.5% | 5,381 | +1608.3% | 0.00% | – |
| Q1 2017 | $3,670,000 | -62.3% | 315 | -85.0% | 0.00% | – |
| Q4 2016 | $9,746,000 | -53.8% | 2,096 | -23.1% | 0.00% | – |
| Q3 2016 | $21,107,000 | +142.7% | 2,727 | +90.0% | 0.00% | – |
| Q2 2016 | $8,696,000 | -90.1% | 1,435 | -80.6% | 0.00% | – |
| Q4 2015 | $88,282,000 | +15.9% | 7,400 | -2.1% | 0.00% | – |
| Q3 2015 | $76,154,000 | +56.1% | 7,555 | +156.9% | 0.00% | – |
| Q2 2015 | $48,791,000 | +387.9% | 2,941 | +355.3% | 0.00% | – |
| Q1 2015 | $10,000,000 | -45.4% | 646 | -62.4% | 0.00% | – |
| Q3 2014 | $18,331,000 | +188.8% | 1,718 | +154.1% | 0.00% | – |
| Q2 2014 | $6,348,000 | +99.2% | 676 | +13.0% | 0.00% | – |
| Q1 2014 | $3,187,000 | +6.9% | 598 | -21.7% | 0.00% | – |
| Q4 2013 | $2,980,000 | – | 764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |